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Abstract 
Background: hemorrhagic transformation is a threatening ischemic stroke complication. Frequency of hemorrhagic 
transformation differs greatly among studies, and its risk factors have been usually studied in patients with anterior 
ischemic stroke who received thrombolytic therapy. We evaluated, in a hospital-based series of patients with posterior 
ischemic stroke not treated with thrombolysis, frequency and risk factors of hemorrhagic transformation. Patients with 
posterior circulation stroke were seen in our Department during the period January 2004 to December 2009. Demo-
graphic and clinical information were collected. We estimated risk for spontaneous hemorrhagic transformation by 
means of uni- and multivariate logistic regression analyses.
Results: 119 consecutive patients were included (73 males, 61.3%). Hemorrhagic transformation was observed in 7 
patients (5.9%). Only clinical worsening was significantly associated with hemorrhagic transformation (OR 6.8, 95% CI 
1.3–34.5).
Conclusions: Our findings indicate that patients with posterior have a low risk of spontaneous hemorrhagic transfor-
mation, suggesting that these patients might have greater advantage from intravenous thrombolysis.
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Background
Neurological and medical complications of ischemic 
stroke (IS) are responsible for higher morbidity and mor-
tality. The former occur earlier than medical complica-
tion, and they affect outcomes with potential serious 
short- and long-term consequences [1]. Though, throm-
bolytic therapy significantly reduces the proportion of 
patients dead or dependent in activities of daily living, it 
also significantly increases the risk of hemorrhagic trans-
formation (HT) of the ischemic lesion, complication that 
independently from more aggressive treatment is associ-
ated with an overall increased mortality [2].
We have previously investigated frequency and risk fac-
tors for HT of the anterior ischemic stroke [3, 4].
Compared to anterior, posterior stroke though less fre-
quent, covering one-fifth of all IS [5] is characterized by 
higher morbidity and mortality [6]. Frequency and risk 
factors for spontaneous HT of the posterior ischemic 
stroke received less attention than those of the carotid 
artery territory.
We have investigated frequency and risk factors for 
spontaneous HT in a sample of patients with posterior 
IS, treated only with conventional therapy, not undergo-
ing thrombolysis. To individuate patients with posterior 
ischemic stroke suitable for thrombolytic therapy, it is 
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critical to estimate frequency of spontaneous HT among 
ischemic stroke patients, and determine its risk factors.
Methods
All consecutive patients diagnosed with posterior circu-
lation stroke (PCS) in our Department during the period 
January 2004 to December 2009, were enrolled in this 
study. Stroke was defined as “rapidly developing clinical 
symptoms and/or signs of focal, and at times global loss 
of cerebral function, with symptoms lasting 24 h or lead-
ing to death, with no apparent cause other than that of 
vascular origin” [7]. Only patients who performed a base-
line brain computed tomography (CT) scan within 24 h 
from symptoms onset and a follow-up CT within 7 days 
from symptoms onset were included in this study.
Patients with transient ischemic attacks (TIA) and cer-
ebral hemorrhage were excluded.
Hemorrhagic transformation was defined as ‘any 
degree of hyperdensity within the area of low attenua-
tion’ [8] and graded using European Cooperative Acute 
Stroke Study (ECASS) classification [9]. ECASS classifies 
hemorrhagic transformation into two classes: hemor-
rhagic infarction (HI) and parenchymal hematoma (PH). 
Each class is further divided into two subtypes. For HI: 
HI-1 is defined as small petechiae along the margins of 
the infarcted area, while HI-2 is characterized by conflu-
ent petechiae within the infarcted area, in the absence of 
any mass effect. For PH: PH-1 is defined as hematoma 
in less than 30% of the infarcted area in the presence of 
only mild mass effect, while PH-2 as hematoma in more 
than 30% of the parenchymal lesion with an evident mass 
effect.
We investigated the following risk factors along with 
demographic variables: history TIA, ischemic or hem-
orrhagic stroke, myocardial infarction, atrial fibrillation, 
diabetes, or arterial hypertension. Cardioembolic ori-
gin of stroke was classified according to the Trial of Org 
10,172 in Acute Stroke Treatment criteria [10]. Continu-
ous variables as determined at patient admission (values 
of systolic and diastolic blood pressure, glycemia, platelet 
count, international normalized ratio, total cholesterol) 
were dichotomized according to their median value. 
History of smoking and alcohol consumption were cat-
egorized in ever smokers versus non-smokers, and ever 
drinker versus non-drinker.
At a first CT scan, the presence of early signs of IS, 
focal hypodensity consistent with the clinical symptoms, 
swelling due to developing infarction, blurring of grey 
matter-white matter distinction, were all assessed by a 
neuroradiologist (C.S.) who was blinded to the clinical 
characteristics of stroke and its progress towards HT.
Level of consciousness at admission was categorized 
in normal/mild (patient alert and responsive to normal 
or loud verbal stimuli) to moderate/severe impairment 
(responsive only to painful stimuli or unresponsive). 
Clinical worsening was defined as worsening of the 
motor deficit and/or the level of consciousness. Writ-
ten informed consent to participate in the study was 
obtained from patients. When patients could not give 
the consent themselves, written assent from the next of 
kin was obtained. The study, as well as informed consent 
signed by the patient or by the next of kin, were approved 
by the local ethic committee of the Palermo University 
Hospital “Paolo Giaccone”.
Statistical analysis
Clinical characteristics of patients with and without HT 
were compared using Chi square test for categorical vari-
ables and t test for continuous variables.
As a measure of association between HT (dependent 
variable) and the variables investigated (independent 
variables) we calculated odds ratios (OR) and 95% con-
fidence intervals (CI), by means of logistic regression 
analysis. These were categorized as it has been described 
in the section methods. The association was considered 
statistically significant for p < 0.05.
If at univariate analysis, more that a variable was found 
significantly associated with HT, a model including these 
variables would have been built (multivariate analysis). 
Statistical analysis was performed using SAS Statistical 
Package Version 9.1.
Results
One-hundred fifty-six patients were admitted to our 
Department during the study period for symptoms attrib-
utable to posterior circulation. Thirty-seven patients, 
who underwent the first brain CT more than 24 h from 
symptoms onset or patients with cerebral hemorrhage or 
TIA, were not included in the study. Finally, 119 patients 
were included (73 males, 61.3%). HT was found in 7 
patients (5.9%). Parenchymal hematoma (PH-1 in 2, PH-2 
in 1) occurred in 3 patients while petechial hemorrhages 
were observed in 4 (HI-1 in 4). Difference of median 
age at admission between patients with (74.5 ± 8.6) and 
without HT (70.3 ±  11.3) was not significant (p =  0.3). 
Table  1 shows the association between HT and some 
demographic data, clinical parameters, neurological 
status on admission, radiological findings and risk fac-
tors for stroke. Cardioembolic origin of stroke was more 
frequent in patients with HT (12.9%) compared to those 
without HT (3.4%) (p  =  0.07). Only clinical worsening 
was still significantly associated with HT (Table 1).
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No significant differences were shown for the other 
variables investigated (values of systolic and diastolic 
blood pressure, platelet count, glycemia, international 
normalized ratio, total, HDL and LDL cholesterol, and 
triglycerides) (Table 2).
Discussion
Main finding of our study is a low incidence of sponta-
neous HT in patients with posterior ischemic stroke 
(5.9%) that reaches even lowest values if we consider only 
PH (2.5%). HT was significantly associated with clinical 
worsening.
To our knowledge, this is the first study investigating 
risk of spontaneous HT in patients with PCS. Indeed, 
most authors investigating hemorrhagic transforma-
tion have focused their attention on anterior circulation 
stroke (ACS), either in patients treated or not with reca-
nalization therapy [11–13].
Measure of HT risk in patients with PCS [14] derives 
from a small sample study investigating frequency and 
relationship of HT to disruption of blood–brain-barrier, 
Table 1 Demographic and  clinical characteristics 
of patients with and without HT
CHD coronary hearth disease
a Data may be not available for all patients
HT/all IS (%) OR (5% CI) p
Gender
 Female 3/46 (6.5)
 Male 4/73 (5.5) 0.8 (0.2, 3.9) 0.8
Age
 < 72.4 2/60 (3.3)
 ≥ 72.4 5/59 (8.5) 2.7 (0.5, 14.4) 0.2
Consciousnessa
 Normal/mild impairment 6/100 (6.0)
 Moderate/severe impairment 1/18 (5.6) 0.9 (0.1, 8.1) 0.9
Clinical  worseninga
 No 4/104 (3.8)
 Yes 3/14 (21.4) 6.8 (1.3, 34.5) 0.02
Early CT signs
 No 4/95 (4.2)
 Yes 3/24 (12.5) 3.2 (0.7, 15.6) 0.1
Infarct size
 Small 0/68 (0)
 Medium to large 7/51 (13.7) – na
Cardioembolic source
 No 3/88 (3.4)
 Yes 4/31 (12.9) 4.2 (0.9, 19.9) 0.07
Atrial fibrillation
 No 4/95 (4.2)
 Yes 3/24 (12.5) 3.2 (0.7, 15.6) 0.1
Hypertensiona
 No 0/31 (0)
 Yes 7/85 (8.2) – na
Diabetesa
 No 3/78 (3.9)
 Yes 4/39 (10.3) 2.9 (0.6, 13.5) 0.2
Dyslipidemiaa
 No 4/89 (4.5)
 Yes 3/26 (11.5) 2.8 (0.6, 13.3) 0.2
Previous  CHDa
 No 4/87 (4.6)
 Yes 3/27 (11.1) 2.6 (0.5, 12.4) 0.2
Smoking habit
 No 3/61 (4.9)
 Yes 4/58 (6.9) 1.4 (0.3, 6.7) 0.6
Alcohol
 No 4/49 (8.2)
 Yes 3/70 (4.3) 0.5 (0.1, 2.4) 0.4
Table 2 Clinical parameters of  patients with  and with-
out HT
SBP systolic blood pressure, DBP diastolic blood pressure
a Data may be not available for all patients
HT (%) OR (5% CI) p
SBP,  mmHga
 < 140 3/67 (4.5)
 ≥ 140 4/48 (8.3) 1.9 (0.4–9) 0.4
DBP,  mmHga
 < 80 5/74 (6.8)
 ≥ 80 2/41 (4.9) 0.7 (0.1–3.8) 0.7
Platelets,  103/µla
 < 214 3/57 (5.3)
 ≥ 214 4/57 (7.0) 0.7 (0.15–3.4) 0.6
INR*
 < 1 2/36 (5.6)
 ≥ 1 5/74 (6.8) 1.2 (0.2–6.7) 0.6
Total cholesterol, mg/dla
 < 193 3/51 (5.9)
 ≥ 193 4/53 (7.5) 1.3 (0.3–6.1) 0.7
HDL, mg/dla
 < 45.5 4/63 (6.3)
 ≥ 45.5 3/37 (8.1) 0.8 (0.1–3.6) 0.7
LDL, mg/dla
 < 109.4 4/40 (10.0)
 ≥ 109.4 2/49 (4.0) 0.4 (0.06–2.2) 0.3
Triglycerides, mg/dla
 < 113.5 3/38 (7.9)
 ≥ 113.5 4/66 (6.0) 0.7 (0.1–3.5) 0.7
Blood glucose, mg/dla
 < 125.5 3/74 (4.0)
 ≥ 125.5 4/38 (10.5) 2.8 (0.6–13.1) 0.2
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detected by MRI. Hemorrhagic transformation was 
observed in 5 (35.7%) out of the 14 patients included. 
In this clinical study, however HT was observed only in 
patients who received pharmacological thrombolysis 
combined with mechanical rechanalization. Therefore, 
the observed reduced frequency of HT in our study (6%) 
when compared to Lee study (35%) very likely depends 
on the more aggressive treatment of the latter. The over-
all lower incidence compared to ACS [15] might find 
an alternative explanation considering stroke territory 
involvement.
One of the major strength of our study is the possibil-
ity to compare frequency of HT between anterior and 
posterior IS in a population sample enrolled in the same 
study period using the same methods. In a larger sample 
of patients with anterior ischemic stroke, we found a fre-
quency of spontaneous HT of 12% [3]. As study period 
of enrollment of the patients, inclusion and exclusion cri-
teria, and clinical assessment were the same of current 
study, difference of frequency of HT between anterior 
and posterior stroke circulation is very likely attributable 
to stroke territory. No patients in both groups underwent 
thrombolysis and no difference existed for treatment 
between the two populations (anterior and posterior 
stroke). It is possible that smaller size of ischemic area of 
PCS might be the explanation of a reduced incidence of 
HT in posterior compared to anterior stroke.
In a study enrolling all patients undergoing intravenous 
thrombolysis, no symptomatic intracranial hemorrhage 
was observed in posterior as compared to a 5% in the 
anterior stroke circulation [15]. The same authors attrib-
uted to an hypothetical reduced volume of infarcts of the 
PCS as compared to larger volume of the ACS.
Lower risk of HT, in PCS as compared to ACS, might 
depend on the fact that occlusions of posterior circula-
tion arteries typically cause ischemic lesion of smaller 
sizes, which may reduce the hemorrhagic transforma-
tion rate. As suggested [16], smaller vessel calibers of 
posterior circulation, especially those of brain stem that 
is nourished by small end-arteries, might be the explana-
tion of smaller size infarcts in PCS. In addition, collater-
als of the posterior circulation might “functionally work” 
better than those of the anterior circulation [17].
Because the size of ischemic stroke [3, 18] was an 
independent risk factor for HT in ACS stroke, higher 
frequency of smaller lesion volume in infratentorial 
compared to supratentorial strokes [19] might partially 
explain lower incidence of hemorrhagic transformation 
in patients with posterior ischemic stroke.
It is well known that size of HT has a great influence 
on the prognosis. All HT observed in our patients with 
clinical worsening were PH (2 PH1, 1 PH2). Fiorelli [20] 
reported for both the placebo and the treatment groups 
an increased risk of early neurological deterioration and 
of 3-month death only when PH size was greater than 
30% of the infarcted area. We have also later demon-
strated [2] that only patients with spontaneous PH and 
not those with HI had a significant eight fold increased 
risk of death at 30 and 90 days from stroke onset. As sug-
gested, to establish whether neurological worsening is 
due to HT itself or due to the size of infarct and the asso-
ciated edema concurrent with HT is still fundamental in 
thrombolysis or other stroke trials [21].
Although only clinical worsening seems to be the main 
predictor of HT in patients with PCS “has been modified. 
The new sentence is: “Although HT in patients with PCS 
is significantly associated only with clinical worsening, 
very likely preceding it, other variables such as cardioem-
bolism, systemic hypertension, dyslipidemia are in our 
study associated with HT, and lack of significance of their 
association is very likely attributable to the small number 
of overall HT in our sample.
Cardioembolism is frequently reported as risk fac-
tor for HT [22], usually causing a large vessel occlusion 
and determining larger infarct and more severe stroke 
[23]. This data suggest that infarct size could reflect the 
embolic origin that could therefore represents the final 
cause of HT. However, atrial fibrillation and infarct area 
independently correlated with risk of spontaneous HT in 
patients with ACS [3, 18]. Atrial fibrillation is associated 
with greater infarct size, more frequent severe HT, and 
worst stroke outcomes [24].
Conversely, in a large US hospital registry study of 
407 patients with PCS, embolism was the most com-
mon mechanism (40% of patients) [25] while large artery 
occlusive lesions was the second cause of hemodynamic 
brain ischemia (32% of patients). Infarcts most often 
included the distal posterior circulation territory, with 
the proximal and the middle territories were equally 
involved.
Main limits of our study, due to methodological issue, 
are the lack of clinical data (NIHSS scores) and of the 
absence of routine MRI scan as neuroimage exam. 
Regarding NIHSS is important to underline that it has 
already been demonstrated that it has limitations in 
detecting neurologic deficits of posterior circulation [26], 
though MRI has advantages for the study of the posterior 
circulation stroke, CT scan remains the exam more fre-
quently used in the emergency setting.
Summing up, our data indicate that patients with PCS 
compared to those with ACS have a lower risk of sponta-
neous hemorrhagic transformation, suggesting that these 
patients might have a greater net benefit from intrave-
nous thrombolysis.
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Conclusions
Results of our study indicate that patients with posterior 
compared to those with anterior stroke seem to have a 
lower risk of spontaneous hemorrhagic transformation, 
finding that might depend by smaller ischemic lesion vol-
umes characterizing posterior stroke. When HT occurs 
in patients with PS, this is significantly associated with 
worsening of symptoms.
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